Here's What Key Metrics Tell Us About Equifax (EFX) Q2 Earnings

22.07.25 15:30 Uhr

Werte in diesem Artikel
Aktien

214,00 EUR -16,00 EUR -6,96%

76,50 EUR 0,50 EUR 0,66%

Indizes

6.309,6 PKT 4,0 PKT 0,06%

For the quarter ended June 2025, Equifax (EFX) reported revenue of $1.54 billion, up 7.4% over the same period last year. EPS came in at $2.00, compared to $1.82 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.51 billion, representing a surprise of +1.51%. The company delivered an EPS surprise of +4.17%, with the consensus EPS estimate being $1.92.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Equifax performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Operating revenue- Asia Pacific: $85.3 million versus $86.43 million estimated by 13 analysts on average. Compared to the year-ago quarter, this number represents a +0.8% change.Operating revenue- Latin America: $99.6 million versus the 13-analyst average estimate of $102.96 million. The reported number represents a year-over-year change of +2.4%.Operating revenue- Europe: $99.2 million versus the 13-analyst average estimate of $91.86 million. The reported number represents a year-over-year change of +12.5%.Operating revenue- Canada: $69.3 million versus $69.4 million estimated by 13 analysts on average. Compared to the year-ago quarter, this number represents a +0.1% change.Operating revenue- Workforce Solutions: $662.1 million versus the 14-analyst average estimate of $652.84 million. The reported number represents a year-over-year change of +8%.Operating revenue- Total International: $353.4 million compared to the $350.25 million average estimate based on 14 analysts. The reported number represents a change of +4.2% year over year.Operating revenue- U.S. Information Solutions: $521.5 million compared to the $509.88 million average estimate based on 14 analysts. The reported number represents a change of +9% year over year.Operating revenue- U.S. Information Solutions- Financial Marketing Services: $63.7 million compared to the $62.55 million average estimate based on 13 analysts. The reported number represents a change of +6% year over year.Operating revenue- Workforce Solutions- Verification Services: $567.1 million versus $558.35 million estimated by 13 analysts on average. Compared to the year-ago quarter, this number represents a +9.9% change.Operating revenue- U.S. Information Solutions- Online Information Solutions: $457.8 million versus the 13-analyst average estimate of $443.97 million. The reported number represents a year-over-year change of +21.2%.Operating revenue- Workforce Solutions- Employer Services: $95 million versus the 13-analyst average estimate of $94.72 million. The reported number represents a year-over-year change of -2.1%.Adjusted EBITDA- U.S. Information Solutions: $182.4 million versus $178.91 million estimated by 11 analysts on average.View all Key Company Metrics for Equifax here>>>Shares of Equifax have returned +1.8% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Equifax, Inc. (EFX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Equifax und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Equifax

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Equifax

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Equifax Inc.

Wer­bung

Analysen zu Equifax Inc.

DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
13.11.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst
13.11.2017Equifax HoldStifel, Nicolaus & Co., Inc.
19.09.2017Equifax OutperformRBC Capital Markets
22.03.2017Equifax BuyStifel, Nicolaus & Co., Inc.
10.02.2017Equifax OverweightBarclays Capital
10.02.2017Equifax BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.02.2019Equifax HoldDeutsche Bank AG
26.10.2018Equifax Equal WeightBarclays Capital
14.12.2017Equifax Equal WeightBarclays Capital
13.11.2017Equifax Sector PerformRBC Capital Markets
23.10.2017Equifax Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Equifax Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen